The vaccine adjuvants market is projected to reach USD 1.2 Billion by 2028 from USD 0.8 Billion in 2023, at a CAGR of 6.9% during the forecast period. Growth in the vaccine adjuvants market can be attributed to factors such as the collaborations and partnerships among market players for the development of vaccine adjuvants, and increasing number of vaccines launch in the market. Request Sample...